December 15, 2022 December 15, 2022Categories News StoriesStudy E1910 consolidates the role of blinatumomab in acute lymphoblastic leukemia (ALL)
December 14, 2022 December 14, 2022Categories News StoriesBlinatumomab further improves survival among patients with B-ALL and a good prognosis (study E1910)
December 13, 2022 December 13, 2022Categories News StoriesImmunotherapy Plus Consolidation Chemo Improves Survival in B Lineage ALL
December 13, 2022 December 13, 2022Categories News StoriesHealthDay News informs the public of the 12-year TAILORx results
December 13, 2022 December 13, 2022Categories News StoriesBlinatumomab regimen may lead to ‘diminishing use of transplant’ for B-ALL subgroup (study E1910)
October 13, 2022 October 13, 2022Categories Announcements News StoriesThe September/October 2022 News from ECOG-ACRIN blog is now available
October 4, 2022 October 4, 2022Categories News StoriesDREAMseq trial clarifies immunotherapy, targeted treatment order for patients with BRAF-mutant metastatic melanoma
September 30, 2022 September 30, 2022Categories News StoriesAdvanced melanoma survival improves significantly when immunotherapy is given before targeted therapy
September 28, 2022 September 28, 2022Categories News StoriesImmunotherapy before targeted therapy improves survival in advanced melanoma, according to the DREAMseq trial
